.

Deeper Knowledge, Faster

  • Predict branded drug patent expiration
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Moodys
Harvard Business School
AstraZeneca
Argus Health
Federal Trade Commission
Medtronic
Boehringer Ingelheim
US Army
Fish and Richardson
Fuji

Generated: July 23, 2017

DrugPatentWatch Database Preview

Saquinavir - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for saquinavir and what is the scope of saquinavir patent protection?

Saquinavir
is the generic ingredient in two branded drugs marketed by Hoffmann La Roche and Hoffmann-la Roche, and is included in three NDAs. There are two patents protecting this compound. Additional information is available in the individual branded drug profile pages.

Saquinavir has thirty-seven patent family members in thirty-four countries.

There is one drug master file entry for saquinavir.

Summary for Generic Name: saquinavir

Tradenames:2
Patents:2
Applicants:2
NDAs:3
Drug Master File Entries: see list1
Bulk Api Vendors: see list28
Clinical Trials: see list89
Patent Applications: see list12,097
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:saquinavir at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Hoffmann La Roche
INVIRASE
saquinavir mesylate
CAPSULE;ORAL020628-001Dec 6, 1995RXYesYes► Subscribe► Subscribe
Hoffmann-la Roche
INVIRASE
saquinavir mesylate
TABLET;ORAL021785-001Dec 17, 2004RXYesYes► Subscribe► Subscribe
Hoffmann La Roche
FORTOVASE
saquinavir
CAPSULE;ORAL020828-001Nov 7, 1997DISCNYesNo6,352,717*PED► SubscribeY► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: saquinavir

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Hoffmann La Roche
FORTOVASE
saquinavir
CAPSULE;ORAL020828-001Nov 7, 19975,196,438*PED► Subscribe
Hoffmann La Roche
FORTOVASE
saquinavir
CAPSULE;ORAL020828-001Nov 7, 19976,008,228*PED► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Ingredient: saquinavir

Country Document Number Estimated Expiration
Brazil9915444► Subscribe
Spain2228141► Subscribe
Turkey200101358► Subscribe
New Zealand511663► Subscribe
Australia1775100► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

Supplementary Protection Certificates for Tradename: SAQUINAVIR

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
/1996Austria► SubscribePRODUCT NAME: SAQUINAVIR UND SEINE SAEUREADDITIONSSALZE, INSBESONDERE SAQUINAVIRMESYLAT; REGISTRATION NO/DATE: EU/1/96/026/001 19961004
C0044Belgium► SubscribePRODUCT NAME: SAQUINAVIR; REGISTRATION NO/DATE: EU/1/96/026/001 19961004
70013Netherlands► SubscribePRODUCT NAME: SAQUINAVIR DESGEWENST IN DE VORM VAN EEN FARMACEUTISCH AANVAARD BAAR ZUURADDITIEZOUT, IN HET BIJZONDER HET MESYLAAT; REGISTRATION NO/DATE: EU/1/96/026/001 19961004
C0048Belgium► SubscribePRODUCT NAME: SAQUINAVIR; REGISTRATION NO/DATE: EU/1/96/026/001 19961004
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Federal Trade Commission
Chubb
QuintilesIMS
Novartis
Cerilliant
Chinese Patent Office
Healthtrust
Johnson and Johnson
Dow
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot